Serum insulin-releasing activity and the Prader-Willi syndrome

Acta Endocrinol Suppl (Copenh). 1986:279:416-21. doi: 10.1530/acta.0.112s416.

Abstract

Pathogenesis and etiology of the various clinical features of the Prader-Willi syndrome (PWS) are not completely understood. There is evidence suggesting a hypothalamic abnormality leading to hypogonadism in this syndrome. To test the possible hypothalamic involvement in the pathogenesis of obesity in these patients we studied the sera of 5 patients with PWS for insulin-releasing activity of possible hypothalamic origin. In addition 4 patients with a PWS-like syndrome and 6 obese patients with signs of central nervous system damage were studied. All five patients with PWS showed significant insulin-releasing activity in their sera. Of the four patients with PWS-like symptoms three showed similar activity while three of the obese patients with central nervous system damage had this activity in their sera. Serum insulin-releasing activity has been shown earlier to be associated with childhood obesity and it could play a role in the pathogenesis of obesity in PWS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Animals
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Hypothalamus / physiopathology
  • In Vitro Techniques
  • Insulin / metabolism*
  • Insulin Secretion
  • Intercellular Signaling Peptides and Proteins
  • Islets of Langerhans / drug effects
  • Islets of Langerhans / metabolism
  • Male
  • Obesity / blood
  • Peptides / blood*
  • Peptides / pharmacology
  • Prader-Willi Syndrome / blood*
  • Rats

Substances

  • Insulin
  • Intercellular Signaling Peptides and Proteins
  • Peptides
  • insulin-glucagon liberin